Formoterol, a Long-Acting β2 Adrenergic Agonist, Improves Cognitive Function and Promotes Dendritic Complexity in a Mouse Model of Down Syndrome

Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years

Heiko Braak, Dietmar Rudolf Thal, Estifanos Ghebremedhin et al. · Journal of Neuropathology & Experimental Neurology · 2011 · 2.2K citations · Full text

Sporadic Alzheimer Disease, Aging, Brain Development +25

Updated national birth prevalence estimates for selected birth defects in the United States, 2004–2006

Samantha E. Parker, T. Cara, Mark A. Canfield et al. · Birth Defects Research Part A Clinical and Molecular Teratology · 2010 · 1.9K citations

Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome

K. E. Wisniewski, Henryk M. Wı́sniewski, G. Y. Wen · Annals of Neurology · 1985 · 1.2K citations

Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study

Quanhe Yang, Sonja A. Rasmussen · The Lancet · 2002 · 829 citations

Down Syndrome, Family Medicine, Population-based Study +7

Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia

William Bondareff, Christopher Q. Mountjoy, Martin Roth · Neurology · 1982 · 689 citations

Neuropsychology, Brain Function, Elderly Patients +22